BioLeap's Series A Round

BioLeap raised a round of funding on January 18, 2010.

BioLeap is an emerging drug discovery company enabled by the next generation of computational fragment-based design technology. BioLeap's design platform quickly predicts binding affinity based on the…

Articles about BioLeap's Series A Round: